News

Latest News

 

read obout major events in our firm:

major projects, partner news and other events of importance.

You can also leave us a message

Peter Prock becomes non executive director of Nupharm

   As already reported, APP advised funds controlled by APAX an the acquisition of Inventfarma and Neuraxpharm - the 2 first companies forming Nupharm. Following the creation of Nupharm, Claudio Albrecht assumed the role of a non executive Director from...

read more

Claudio Albrecht becomes interim CEO of Stada AG

    On September 27, 2017 the Supervisory Board of STADA Arzneimittel AG appointed Dr. Claudio Albrecht as new Chairman of the Executive Board with immediate effect. Dr. Albrecht succeeds Engelbert Coster Tjeenk Willink who had held the office of Chairman of...

read more

APP advises consortium on Stada

    Funds advised by Bain Capital Private Equity, LP (“Bain Capital”) and by Cinven Partners LLP (“Cinven”), announced the intention to launch a voluntary public takeover offer (the “Takeover Offer”) for all outstanding shares of STADA Arzneimittel AG...

read more

Sean Bowler joins APP

   We are delighted to announce that Sean Bowler joins APP as Partner. Sean is an engineer who has been Head of Global Engineering and HSE in several major pharmaceutical companies. He has successfully developed and managed corporate systems in areas such as...

read more

contact us

Albrecht, Prock & Partners AG

Bödlistrasse 3c

CH-6314 Unteraegeri - Zug, Switzerland

office(at)ca-pp.net

1 + 13 =